Switch to:
More From Other Websites
Congress unites in scorn for Shkreli, but gridlock remains Feb 05 2016
Congress unites in scorn for Shkreli, but gridlock remains Feb 05 2016
The Real Lesson of the Shkreli Circus Feb 05 2016
Valeant's Share Price Continues to Decline Feb 05 2016
Shkreli theatrical display misses core biotech pricing issues Feb 05 2016
CRI Advanced Hound Partners in January. VRX dragged Feb 05 2016
So, Bill Ackman Makes Some Good Points on the Index Bubble... Feb 05 2016
[$$] Valeant Needs More Volume Amid the Noise Feb 05 2016
[$$] Martin Shkreli Pleads the Fifth Before Congress Feb 05 2016
[$$] Martin Shkreli Takes the Fifth Before Congress Feb 04 2016
After The Martin Shkreli Circus, How Can We Fix Drug Pricing? Feb 04 2016
[$$] Valeant Needs More Volume Amid the Noise Feb 04 2016
Rep. John Mica: Shkreli Was Arrogant Feb 04 2016
It’s Time to Buy This Biotech Gem Feb 04 2016
Shkreli, Valeant Go To Washington -- Recap Feb 04 2016
Smirks, silence and nerves: Recap of the drug pricing hearing with Shkreli Feb 04 2016
How Martin Shkreli Is ‘Trashing’ the Pharma Industry Feb 04 2016
TW Drove ValueAct’s Performance in January. VRX did not Feb 04 2016
Expectations for Valeant Pharmaceuticals in 2016 Feb 04 2016
Valeant, Turing Slammed as Shkreli Calls Congress ‘Imbeciles’ Feb 04 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK